| Videos | Channels | Search |
Prof. Peter Rossing on diabetes complications
Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)
05:34 minutes
Tags: cardiovascular complications, early intervention, early prediction, End-stage renal disease, ESRD, Jesper Eugen-Olsen, Jørgen Jeppesen, late stage complications, Persson F, risk prediction, Simone Theilade, soluble urokinase plasminogen activator receptor, suPAR, Tine W. Hansen, Tofte N, Type 1 diabetes, Viktor Curovic, Winther SA